A multi-national prospective study assessing efficacy and safety of nonacog gamma for perioperative use in previously-treated patients with severe or moderately severe hemophilia B.

Trial Profile

A multi-national prospective study assessing efficacy and safety of nonacog gamma for perioperative use in previously-treated patients with severe or moderately severe hemophilia B.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Nonacog gamma (Primary)
  • Indications Haemophilia B
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Jan 2017 New trial record
    • 06 Dec 2016 Results of all 38 surgeries assessing safety and efficacy of Nonacog gamma presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top